Skip to content
Visnia
CtrlK
EconomyAI buildoutMarket MapFundsWatchlist
Log in
Market cap
Revenue
Net income
Cash on hand
Gross margin
Net margin
EPS
P/E ratio
Search
Market mapFundsWatchlist
Visnia

GLakefront Biotherapeutics NV

EconomyAI buildoutMarket MapFundsWatchlist
Log in
G

Lakefront Biotherapeutics NV

  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Similar companies
  • News
  • Insider Transactions

Loading earnings…

  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Similar companies
  • Insider Transactions
YearRevenue YoYGross marginCash & equivalents
YearRevenue YoYGross marginCash & equivalents
(Filed on March 26, 2026)
+354.8%97.3%$103.3M

Filing text is unavailable for this period.

(Filed on March 26, 2026)
+8.3%87.4%$67M
(Filed on March 26, 2026)
+3.2%—$184.7M
(Filed on March 27, 2025)
-3.1%95.0%$541.7M
(Filed on March 28, 2024)
-54.7%99.3%$2.5B
(Filed on March 23, 2023)
-37.4%—$2.6B
(Filed on March 24, 2022)
+193.4%—$2.1B
(Filed on March 25, 2021)
+109.8%—$1.5B
(Filed on March 27, 2020)
+11.6%—$1.4B
(Filed on March 29, 2019)
+215.5%—$1B
(Filed on March 23, 2018)
——$371.3M